The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding Company's latest marketcap:
As of 07/19/2026, The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding Company's market capitalization has reached $69.49 M. According to our data, The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding Company is the 28290th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 69.49 M |
| Revenue (ttm) | 34.55 M |
| Net Income (ttm) | 6.87 M |
| Shares Out | 33.7 M |
| EPS (ttm) | 0.2 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 07/30/2026 |
The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding Company's yearly market capitalization.
| Date | Market Cap(د.أ) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/19/2026 | د.أ49.2 M | $69.49 M | 28290 |
Company Profile
The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding Company, together with its subsidiaries, develops, manufactures, and sells branded generic pharmaceuticals in Jordan and internationally.
It offers its products in various forms, such as tablets, capsules, suppositories, injectable, syrups and suspensions.
The company provides various pharmaceutical products, such as cardiovascular, gastrointestinal, central nervous system, anti-infective, endocrine, musculoskeletal, respiratory, obstetrics, gynecology and urinary tract, immune system, anti-diabetics, anti-inflammatory and analgesic, musculoskeletal, and genitourinary drugs, as well as vitamins and supplements.
It is also involved in the development and production of plant and herbal medical products; and diagnostic test kits for home and laboratory use, as well as focuses on the development of proprietary, specialized drug delivery systems, and pharmaceutical additives.
The company was founded in 1978 and is headquartered in Naour, Jordan.
Frequently Asked Questions
-
What is The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding Company's (ASE-JPHM) current market cap?As of 07/19/2026, The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding Company (including the parent company, if applicable) has an estimated market capitalization of $69.49 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding Company (ASE-JPHM) rank globally by market cap?The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding Company global market capitalization ranking is approximately 28290 as of 07/19/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.